Preformulation Characterization of an Aluminum Salt-Adjuvanted Trivalent Recombinant Protein-Based Vaccine Candidate Against Streptococcus Pneumoniae
- 1 September 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 101 (9), 3078-3090
- https://doi.org/10.1002/jps.23175
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Formulation development of a plant-derived h1n1 influenza vaccine containing purified recombinant hemagglutinin antigenHuman Vaccines & Immunotherapeutics, 2012
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Unmet needs in modern vaccinologyVaccine, 2010
- Implementation of an FTIR calibration curve for fast and objective determination of changes in protein secondary structure during formulation developmentJournal of Pharmaceutical and Biomedical Analysis, 2010
- Role of the manganese efflux system mntE for signalling and pathogenesis in Streptococcus pneumoniaeMolecular Microbiology, 2009
- Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodiesThe Journal of Experimental Medicine, 2007
- Solution Behavior of IFN-β-1a: An Empirical Phase Diagram Based ApproachJournal of Pharmaceutical Sciences, 2005
- Effects of Adsorption to Aluminum Salt Adjuvants on the Structure and Stability of Model Protein AntigensJournal of Biological Chemistry, 2005
- Derivative Absorbance Spectroscopy and Protein Phase Diagrams as Tools for Comprehensive Protein Characterization: A bGCSF Case StudyJournal of Pharmaceutical Sciences, 2003
- Rate of disappearance of diphtheria toxoid injected into rabbits and guinea ‐ pigs: Toxoid precipitated with alumThe Journal of Pathology and Bacteriology, 1931